Mulmit

NEOGEN CORPNEOGEN CORP

NEOG Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2026-05-31870,400,000-21,600,000-7,900,000-0.04
2025-05-31894,700,000-1,061,000,000-1,092,000,000-5.03
2024-05-31924,200,00058,600,000-9,400,000-0.04
2023-05-31822,447,00037,515,000-22,870,000-0.12
2022-05-31527,159,00058,618,00048,307,0000.45

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-19Moylan John PatrickChief Accounting Officer2,365
2026-08-19Nassif MikhealCEO20,397
2026-08-14Moylan John PatrickChief Accounting Officer8,584
2026-08-14Moylan John PatrickChief Accounting Officer18,693
2026-08-14Ranalli Tamara A.Senior Vice President25,751
2026-08-14Ranalli Tamara A.Senior Vice President130,851
2026-08-14Stacey Jennifer EvansChief Legal Officer38,627
2026-08-14Stacey Jennifer EvansChief Legal Officer196,276
2026-08-14Riggsbee Richard BryanCFO51,502
2026-08-14Riggsbee Richard BryanCFO261,702
2026-08-14Nassif MikhealCEO141,631
2026-08-14Nassif MikhealCEO719,679

8-K events

FiledItems
2026-08-07Officer or director change
2026-07-30Results of operations · Financial statements and exhibits
2026-04-20Regulation FD disclosure · Financial statements and exhibits
2026-04-09Results of operations · Financial statements and exhibits
2026-03-30Officer or director change
2026-01-08Results of operations · Financial statements and exhibits
2025-10-30Officer or director change · Other events · Financial statements and exhibits
2025-10-28Officer or director change · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

In Vitro & In Vivo Diagnostic Substances — 같은 업종, 그리고 규모가 비슷한 기업In Vitro & In Vivo Diagnostic Substances — and other companies of a similar size

SEC가 같은 업종(In Vitro & In Vivo Diagnostic Substances)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (In Vitro & In Vivo Diagnostic Substances) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.